Hbk Investments L P Bausch Health Companies Inc. Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $7.42 Million - $9.57 Million	-361,737 Reduced 96.56%	12,900 $325,000
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $3.96 Million - $5.15 Million	-195,763 Reduced 34.32%	374,637 $9.25 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $2.64 Million - $4.25 Million	-149,933 Reduced 20.81%	570,400 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $14.9 Million - $18.5 Million	720,333 New	720,333 $18.5 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.